CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Schrödinger Raises 2026 ACV Guidance to $222 Million-$232 Million

By Public Technologies
  • Schrödinger raised its 2026 annual contract value guidance to $222 million–$232 million, representing 12%–17% growth.
  • Drug discovery revenue is now forecast at $75 million–$85 million, up from $65 million–$75 million.
  • Operating expenses are expected to be lower than in 2025.
  • Third-quarter 2026 revenue rose 19% to $64.5 million, supporting the improved outlook.
  • The company targets positive adjusted EBITDA by the end of 2028, with annual contract value growth of 10%–15% annually.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Schrodinger Inc. published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk